Lexaria Bioscience Corp

Lexaria Bioscience Corp operates as a biotechnology company Its patented drug delivery technology DehydraTECH improves the way active pharmaceutical ingredients enter the bloodstream by promoting effective oral delivery The companys DehydraTECH has demonstrated the ability to increase bioabsorption with cannabinoids and nicotine by 510x and in some instances with cannabinoids by 27x compared to standard industry formulations reduce time of onset from 1 2 hours to minutes and mask unwanted tastes and is also being evaluated for orally administered antiviral drugs nonsteroidal antiinflammatory drugs NSAIDs PDE5 inhibitors and others DehydraTECH also deliver drugs effectively across the blood brain barrier It operates a licensed inhouse research laboratory and holds intellectual property portfolio with 23 patents granted and approximately 50 patents pending worldwide Lexaria Bioscience Corp was incorporated in 2004 and is headquartered in Kelowna Canada